BioSpace News Archive

Business

Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019

Q4 2019 DecisionDx-Melanoma test report volume increased 37% compared to Q4 2018

January 9, 2020
·
7 min read
Business

Rockwell Medical, Inc. Appoints Russell H. Ellison, MD, MSc, to Board of Directors

Dr. Ellison has held leadership positions in both emerging biotechnology and large pharmaceutical companies for more than four decades.

January 9, 2020
·
7 min read
Deals

Galen, an Almac Group Company, Announces Completion of Multi-Million Pound POA Pharma Acquisition

Galen, a member of the Almac Group and privately owned global pharmaceutical sales and marketing company, today announced the completion of a multi-million pound acquisition and takeover of boutique healthcare company, POA Pharma.

January 9, 2020
·
3 min read
Drug Development

AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD at Biotech Showcase 2020 Conference (January 13) in San Francisco

Initial data from the first five patients indicate positive trends for all primary and secondary safety and efficacy endpoints in AzurRx’s Phase 2 Clinical Study for MS1819-SD, in combination with standard PERT for Cystic Fibrosis patients with severe exocrine pancreatic insufficiency.

January 9, 2020
·
5 min read
Business

Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million

Fourth Quarter Net Revenues of Andexxa Expected to be Approximately $28 Million Including $4 Million in Fourth Quarter Sales from Ondexxya in Europe

January 9, 2020
·
9 min read
Business

QIAGEN Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony

Milestone instrument placed with Cenata GmbH in Germany

January 9, 2020
·
6 min read
Deals

Aptinyx Announces Proposed Public Offering of Common Stock - Jan. 9, 2020

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

January 9, 2020
·
3 min read
Business

T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer

T2 Biosystems, Inc., a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced that its Board of Directors has appointed diagnostics industry veteran John Sperzel as President and Chief Executive Officer, effective immediately.

January 9, 2020
·
5 min read
Business

BD Announces Live Webcast Of First Fiscal Quarter 2020 Earnings Conference Call

BD announced that it will conduct a live webcast of its first fiscal quarter 2020 earnings conference call on Thursday, February 6, 2020, at 8:00 a.m.

January 9, 2020
·
1 min read
Business

CytomX Therapeutics Deploys Genedata Bioprocess

CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment

January 9, 2020
·
3 min read